Stryker Corporation $SYK Shares Sold by Stonehage Fleming Financial Services Holdings Ltd

Key Points

• Stonehage Fleming Financial Services Holdings Ltd trimmed its position in Stryker by 3.3%, selling 14,771 shares and holding 434,666 shares worth about $152.8 million at quarter-end, representing roughly 4.7% of that fund's portfolio.
• Stryker beat quarterly expectations with $4.47 EPS vs. $4.40 and revenue of $7.17 billion (up 11.4% year-over-year), and analysts maintain a consensus rating of Moderate Buy with an average price target of $427.50.
• Director Ronda E. Stryker sold 250,000 shares at an average $362.92 (≈$90.7 million), reducing her ownership by 9.23%; insiders now own about 5.9% of the company.

Stonehage Fleming Financial Services Holdings Ltd lowered its position in Stryker Corporation (NYSE:SYK - Free Report) by 3.3% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 434,666 shares of the medical technology company's stock after selling 14,771 shares during the period. Stryker accounts for approximately 4.7% of Stonehage Fleming Financial Services Holdings Ltd's portfolio, making the stock its 12th biggest holding. Stonehage Fleming Financial Services Holdings Ltd owned approximately 0.11% of Stryker worth $152,772,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Clayton Financial Group LLC acquired a new stake in shares of Stryker in the third quarter valued at about $26,000. United Financial Planning Group LLC purchased a new position in shares of Stryker in the third quarter worth about $27,000. Elevation Point Wealth Partners LLC acquired a new position in Stryker during the second quarter worth about $28,000. Kilter Group LLC acquired a new position in Stryker during the second quarter worth about $29,000. Finally, Howard Hughes Medical Institute purchased a new stake in Stryker during the 2nd quarter valued at about $29,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Raymond James Financial upgraded shares of Stryker from a "market perform" rating to an "outperform" rating and set a $418.00 price objective for the company in a report on Tuesday, January 6th. Barclays restated an "overweight" rating and issued a $469.00 price target on shares of Stryker in a research report on Monday, February 2nd. TD Cowen cut Stryker from a "buy" rating to a "hold" rating and set a $387.00 price target for the company. in a report on Monday, January 26th. Truist Financial reduced their price objective on Stryker from $400.00 to $392.00 and set a "hold" rating on the stock in a research report on Thursday, December 18th. Finally, Citigroup reissued a "market outperform" rating on shares of Stryker in a research note on Friday, January 30th. Fourteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $427.50.

Stryker Price Performance

Shares of SYK stock opened at $332.58 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. The company has a market capitalization of $127.37 billion, a PE ratio of 39.59, a price-to-earnings-growth ratio of 1.92 and a beta of 0.85. The firm's 50-day moving average is $360.91 and its two-hundred day moving average is $364.35. Stryker Corporation has a 12 month low of $324.93 and a 12 month high of $404.87.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating the consensus estimate of $4.40 by $0.07. The business had revenue of $7.17 billion during the quarter, compared to analysts' expectations of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.01 EPS. Analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Tuesday, March 31st. Stryker's dividend payout ratio is presently 41.90%.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the firm's stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares of the company's stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 5.90% of the company's stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.